Market Exclusive

Nu Skin Enterprises, Inc. (NYSE:NUS) price target lowered to $4.00 by DA Davidson

Analyst Ratings For Nu Skin Enterprises, Inc. (NYSE:NUS)

Today, DA Davidson lowered its price target on Nu Skin Enterprises, Inc. (NYSE:NUS) to $4.00 per share.

There are 5 Buy Ratings, 2 Hold Ratings, 1 Sell Ratings, no Strong Buy Ratings on the stock.

The current consensus rating on Nu Skin Enterprises, Inc. (NYSE:NUS) is Buy with a consensus target price of $69.4286 per share, a potential 6.19% upside.

Some recent analyst ratings include


About Nu Skin Enterprises, Inc. (NYSE:NUS)
Nu Skin Enterprises, Inc. develops and distributes anti-aging personal care products and nutritional supplements under the Nu Skin and Pharmanex category brands worldwide. It provides skin care systems and targeted treatment products, including ageLOC Me customized skin care systems, ageLOC Spa systems, and ageLOC LumiSpa skin treatment and cleansing devices; and Epoch products, as well as a range of other cosmetic, personal care, and hair care products. The company also offers ageLOC Youth nutritional supplements, ageLOC TR90 weight management and body shaping systems, and LifePak nutritional supplements, as well as other anti-aging nutritional solutions and weight management products. In addition, it is involved in the research and product development of skin care products and nutritional supplements. Further, the company operates walk-in centers and pick-up locations; and retail stores and service centers in Mainland China. The company sells its products directly, as well as through distributors and Website. Nu Skin Enterprises, Inc. was founded in 1984 and is headquartered in Provo, Utah.

Recent Trading Activity for Nu Skin Enterprises, Inc. (NYSE:NUS)
Shares of Nu Skin Enterprises, Inc. closed the previous trading session at 65,39 up +1,41 2,20 % with shares trading hands.

Exit mobile version